Evidence map›Paper›PMID 30904283›Full record

ReviewSeminars in immunology2019

Tissue-resident cytotoxic innate lymphoid cells in tumor immunosurveillance.

Efstathios G Stamatiades, Ming O Li

Open access · greenAbstract readReview
In one paragraph

Review in Seminars in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. CD49aBritish journal of cancer · 2025
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Overview: Themes in Innate Lymphoid Cell Biology.Advances in experimental medicine and biology · 2022
    Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Efstathios G StamatiadesImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Ming O LiImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. Electronic address: lim@mskcc.org.
Memorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Ontogeny and Function of Tumor-associated MacrophagesR01CA198280 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI LI, MING · 2015 to 2019
$2.3M
Howard Hughes Medical InstituteNCI NIH HHS P30 CA008748NCI NIH HHS R01 CA198280
6 · The paper itself

Abstract

Innate lymphocytes play an important role in maintaining tissue homeostasis at steady state and during inflammation. The population of innate lymphocytes is incredibly diverse and heterogeneous with the successive identification of new subsets including innate lymphoid cells that arise from progenitors distinct from those of natural killer cells. Although generally considered as T helper-like lymphocytes, innate lymphoid cells with cytotoxic potential can be identified in many tissues. The tissue-resident cytotoxic innate lymphocytes derived from innate lymphoid cell and/or natural killer cell lineages are well positioned in sensing malignant transformation and initiating antitumor immunity. This review provides an overview of innate lymphocyte biology and discuss their roles in tumor immunosurveillance.

Indexed as

Cytotoxicity, ImmunologicImmunity, InnateImmunologic SurveillanceAnimalsCell Transformation, NeoplasticHumansKiller Cells, NaturalLymphocyte SubsetsLymphoid TissueNeoplasmsOrgan SpecificityTumor MicroenvironmentCytotoxicityInnate lymphoid cellsNK cellsTumor immunosurveillance

Identifiers

PMID30904283
PMCPMC6733035
OpenAlexW2924944118

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.